Gastric Bypass and Influence on Improvement of NAFLD

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Purpose of Review: Obesity is recognized as a chronic and recurring disease, often accompanied by other weight-related comorbid conditions such as obstructive sleep apnea, hypertension, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). This chapter will seek to focus on the effect of weight loss surgery (WLS), in particular Roux-en-Y gastric bypass (RYGB), on NAFLD. Recent Findings: Among several modalities available to treat NAFLD, the one most likely to achieve rapid, significant, and sustained improvement of liver disease is WLS. Summary: The most commonly studied WLS procedure at this time is RYGB, and there is significant evidence that this is a safe and effective procedure both for weight loss and to bring about improvement of multiple associated comorbid conditions, including NAFLD. Further research focusing on non-surgical approaches that might mimic the effect of WLS on liver pathology is needed.

Original languageEnglish (US)
Article number25
JournalCurrent Gastroenterology Reports
Volume19
Issue number6
DOIs
StatePublished - Jun 1 2017

Fingerprint

Gastric Bypass
Weight Loss
Obstructive Sleep Apnea
Type 2 Diabetes Mellitus
Liver Diseases
Chronic Disease
Obesity
Non-alcoholic Fatty Liver Disease
Pathology
Hypertension
Weights and Measures
Liver
Research

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

@article{8edf532626b04c4683d4d6199b3fcfe4,
title = "Gastric Bypass and Influence on Improvement of NAFLD",
abstract = "Purpose of Review: Obesity is recognized as a chronic and recurring disease, often accompanied by other weight-related comorbid conditions such as obstructive sleep apnea, hypertension, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). This chapter will seek to focus on the effect of weight loss surgery (WLS), in particular Roux-en-Y gastric bypass (RYGB), on NAFLD. Recent Findings: Among several modalities available to treat NAFLD, the one most likely to achieve rapid, significant, and sustained improvement of liver disease is WLS. Summary: The most commonly studied WLS procedure at this time is RYGB, and there is significant evidence that this is a safe and effective procedure both for weight loss and to bring about improvement of multiple associated comorbid conditions, including NAFLD. Further research focusing on non-surgical approaches that might mimic the effect of WLS on liver pathology is needed.",
author = "Vamsi Alli and Ann Rogers",
year = "2017",
month = "6",
day = "1",
doi = "10.1007/s11894-017-0567-8",
language = "English (US)",
volume = "19",
journal = "Current Gastroenterology Reports",
issn = "1522-8037",
publisher = "Current Medicine Group",
number = "6",

}

Gastric Bypass and Influence on Improvement of NAFLD. / Alli, Vamsi; Rogers, Ann.

In: Current Gastroenterology Reports, Vol. 19, No. 6, 25, 01.06.2017.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Gastric Bypass and Influence on Improvement of NAFLD

AU - Alli, Vamsi

AU - Rogers, Ann

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Purpose of Review: Obesity is recognized as a chronic and recurring disease, often accompanied by other weight-related comorbid conditions such as obstructive sleep apnea, hypertension, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). This chapter will seek to focus on the effect of weight loss surgery (WLS), in particular Roux-en-Y gastric bypass (RYGB), on NAFLD. Recent Findings: Among several modalities available to treat NAFLD, the one most likely to achieve rapid, significant, and sustained improvement of liver disease is WLS. Summary: The most commonly studied WLS procedure at this time is RYGB, and there is significant evidence that this is a safe and effective procedure both for weight loss and to bring about improvement of multiple associated comorbid conditions, including NAFLD. Further research focusing on non-surgical approaches that might mimic the effect of WLS on liver pathology is needed.

AB - Purpose of Review: Obesity is recognized as a chronic and recurring disease, often accompanied by other weight-related comorbid conditions such as obstructive sleep apnea, hypertension, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD). This chapter will seek to focus on the effect of weight loss surgery (WLS), in particular Roux-en-Y gastric bypass (RYGB), on NAFLD. Recent Findings: Among several modalities available to treat NAFLD, the one most likely to achieve rapid, significant, and sustained improvement of liver disease is WLS. Summary: The most commonly studied WLS procedure at this time is RYGB, and there is significant evidence that this is a safe and effective procedure both for weight loss and to bring about improvement of multiple associated comorbid conditions, including NAFLD. Further research focusing on non-surgical approaches that might mimic the effect of WLS on liver pathology is needed.

UR - http://www.scopus.com/inward/record.url?scp=85018460313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018460313&partnerID=8YFLogxK

U2 - 10.1007/s11894-017-0567-8

DO - 10.1007/s11894-017-0567-8

M3 - Review article

C2 - 28429199

AN - SCOPUS:85018460313

VL - 19

JO - Current Gastroenterology Reports

JF - Current Gastroenterology Reports

SN - 1522-8037

IS - 6

M1 - 25

ER -